71 filings
Page 4 of 4
8-K
5schdjwuxsdv9e1296t
27 May 20
CNS Provides Update on Development
5:15pm
8-K
q03tvler
18 May 20
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
5:23pm
8-K
qkvbhgbu
26 Mar 20
Entry into a Material Definitive Agreement
4:30pm
8-K
yv9o och4g6r8d1vf6y
12 Mar 20
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
4:29pm
8-K
mljpko qcnt4oo1klv
10 Mar 20
Regulation FD Disclosure
4:05pm
8-K
jr88jaax 0x
2 Mar 20
Regulation FD Disclosure
2:15pm
8-K
235q5mwkk0bm mhi
16 Jan 20
Entry into a Material Definitive Agreement
4:40pm
8-K
pt103gg69b1uuegg
16 Jan 20
Regulation FD Disclosure
10:18am
8-K
vbch 1lzl9epln42mpk
13 Jan 20
Regulation FD Disclosure
10:24am
8-K
qouj24qy7iz xhe8s
22 Nov 19
CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
8:00am
8-K
t4e3g
14 Nov 19
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
12:00am